III John Osborne Lilly
CIK 1897305 · last filed 2026-07-14
III John Osborne Lilly is a corporate insider who has filed 10 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider was granted $14.7K of DUOL on Jul 14, 2026. Across all open-market trades the lifetime net is +$2.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.98M
2
10
$2.06M
Holdings By Company
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-14 | DUOL | Grant (A) | +118 | $14.7K | EDGAR |
| 2026-06-05 | DUOL | Grant (A) | +2,001 | $0 | EDGAR |
| 2026-06-04 | FIG | Grant (A) | +12,415 | $0 | EDGAR |
| 2026-04-15 | FIG | Other (J) | +422 | $0 | EDGAR |
| 2025-08-05 | FIG | Buy (P) | +62,500 | $2.06M | EDGAR |
| 2025-06-18 | DUOL | Grant (A) | +379 | $0 | EDGAR |
| 2024-06-14 | DUOL | Grant (A) | +895 | $0 | EDGAR |
| 2023-06-20 | DUOL | Grant (A) | +1,016 | $0 | EDGAR |
| 2022-06-13 | DUOL | Grant (A) | +1,664 | $0 | EDGAR |
| 2021-12-16 | DUOL | Grant (A) | +2,950 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.